Genetic dissection of familial combined hyperlipidemia

Molecular Genetics and Metabolism

Volumn 74, Issue 1-2, 2001, Pages 98-104

  Eurlings, Petra M H ^a   Van Der Kallen, Carla J H ^a   Geurts, Jan M W ^a   Van Greevenbroek, Marleen M J ^a   De Bruin, Tjerk W A ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Animal models; Differential gene expression; FCHL; Genome wide screens

Indexed keywords

CHOLESTEROL; TRIACYLGLYCEROL;

ANIMAL MODEL; CHOLESTEROL BLOOD LEVEL; DOMINANT INHERITANCE; FAMILIAL DISEASE; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC DISORDER; GENETIC LINKAGE; GENOME; HYPERLIPIDEMIA; ISCHEMIC HEART DISEASE; PHENOTYPE; PRIORITY JOURNAL; SHORT SURVEY; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALIA;

EID: 0034793988     PISSN: 10967192     EISSN: None     Source Type: Journal    
DOI: 10.1006/mgme.2001.3232     Document Type: Article

References (35)

1. Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia
2. Defects of lipoprotein metabolism in familial combined hyperlipidemia
3. Impaired chylomicron remnant clearance in familial combined hyperlipidemia
4. Lipoprotein metabolism in FCHL
5. Defects of insulin action on fatty acid and carbohydrate metabolism in familial combined hyperlipidemia
6. Relationship of insulin sensitivity and ApoB levels to intra-abdominal fat in subjects with familial combined hyperlipidemia
7. Acute effects of insulin in the control of VLDL production in humans. Implications for the insulin-resistant state
8. Complex segregation analysis of hyperlipidemia in a Seattle sample
9. Complex segregation analysis provides evidence for a major gene acting on serum triglyceride levels in 55 British families with familial combined hyperlipidemia
10. Linkage of familial combined hyperlipidaemia to chromosome 1q21-q 23
11. A genome scan for familial combined hyperlipidemia reveals evidence of linkage with a locus on chromosome 11
12. Genomewide scan for familial combined hyperlipidemia genes in Finnish families, suggesting multiple susceptibility loci influencing triglyceride, cholesterol, and apolipoprotein B levels
13. Novel genes for familial combined hyperlipidemia
14. Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats
15. The hormone resistin links obesity to diabetes
16. Apolipoprotein B overproduction by the perfused liver of the St. Thomas' mixed hyperlipidemic (SMHL) rabbit
17. Mapping a gene for combined hyperlipidaemia in a mutant mouse strain
18. Fine mapping of Hyplip1 and the human homolog, a potential locus for FCHL
19. New insights into atherosclerosis from studies with mouse models
20. Support for linkage of familial combined hyperlipidemia to chromosome 1q21-q 23 in Chinese and German families
21. Replication of linkage of familial combined hyperlipidemia to chromosome 1q with additional heterogenous effect on apolipoprotein A-I/C-III/A-IV Locus
22. Linkage of a candidate gene locus to familial combined hyperlipidemia - Lecithin:cholesterol acyltransferase on 16q
23. Genome scan for adiposity in Dutch dyslipidemic families reveals novel quantitive trait loci for leptin, body mass index and soluble tumor necrosis factor receptor superfamily 1A
24. Population choice in mapping genes for complex diseases
25. Regulatory mutations in the human lipoprotein lipase gene in patients with familial combined hyperlipidemia and coronary artery disease
26. A mutation in the promoter of the lipoprotein lipase (LPL) gene in a patient with familial combined hyperlipidemia and low LPL activity
27. The lipoprotein lipase (Asn291 → Ser) mutation is associated with elevated lipid levels in families with familial combined hyperlipidaemia
28. Lipoprotein lipase gene mutations D 9N and N291S in four pedigrees with familial combined hyperlipidaemia
29. Complex genetic contribution of the Apo AI-CIII-AIV gene cluster to familial combined hyperlipidemia. Identification of different susceptibility haplotypes
30. Apolipoprotein A-I/C-III/A-IV gene cluster in familial combined hyperlipidemia: Effects on LDL-cholesterol and apolipoproteins B and C-III
31. Contribution of the hepatic lipase gene to the atherogenic lipoprotein phenotype in familial combined hyperlipidemia
32. The Pro12Ala substitution in the peroxisome proliferator activated receptor gamma 2 is associated with an insulin-sensitive phenotype in families with familial combined hyperlipidemia and in non-diabetic elderly subjects with dyslipidemia
33. Identification of TNFRSF 1B as a novel modifier gene in familial combined hyperlipidemia
34. Suppression subtractive hybridization: A versatile method for identifying differentially expressed genes
35. Genome-scan for blood pressure in Ductch dyslipidemis families reveals linkage to a locus on chromosome 4p